Name Steward Organization Suggested Domain Suggested Domain Description Cde Group Classification
3. Has the participant ever experienced amyloid related imaging abnormalities-edema (ARIA-E), amyloid related imaging abnormalities-hemorrhage (ARIA-H), or other major adverse events associated with treatments expected to modify ADRD biomarkers? NACC Treatment
Treatment for all conditions
 Other NIA-funded studies
  • ▼ NACC
    • ▼ Uniform Data Set
      • ▼ Form name- A4a: ADRD-Specific Treatments
        • ▼ Packet- Initial Visit Packet
          • Variable name- advevent

# Datatype

UUID: 974ba33a-c06e-5c49-a0aa-15e364877fac

Value List

# Permissible value Value meaning name

UUID: 53c978b2-c176-5c58-874c-4f3324775bfe

0 No

UUID: f858d03b-7570-5665-90f4-bd0824e6f5ad

1 Yes

UUID: 027dfa61-630c-5644-937a-befaa960e1c6

9 Unknown

# Identifier Origin Version

UUID: 0c6e9478-aeb9-5173-b3d0-bef3998c099f

UDS_a4a_Initial Visit Packet_advevent NACC-source_dataset+form_name+packet+var_name NACC_uds-v4-ivp-ded-11122025